Identification of a novel gene fusion RNF213-SLC26A11 in chronic myeloid leukemia by RNA-Seq

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 591-597

  Zhou, Jian Bo ^a   Zhang, Ting ^a   Wang, Ben Fang ^a   Gao, Hai Zhen ^a   Xu, Xin ^a  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

BCR ABL; Chronic myeloid leukemia; Gene fusion; Reverse transcription polymerase chain reaction; RNA sequencing

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; BREAKPOINT CLUSTER REGION PROTEIN; HYBRID PROTEIN; RING FINGER PROTEIN; RNF213 SLC26A11 FUSION PROTEIN; SULFATE; UNCLASSIFIED DRUG;

ABELSON MURINE LEUKEMIA ONCOVIRUS; AGED; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; CASE REPORT; CHINESE; CHROMOSOME 17; CHROMOSOME 22; CHROMOSOME 9; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; DISEASE DURATION; FILTRATION; GENE EXPRESSION; GENE FUSION; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; MALE; MEDICAL HISTORY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS ONCOGENE;

AGED; GENE FUSION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MEMBRANE TRANSPORT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA; UBIQUITIN-PROTEIN LIGASES;

EID: 84873875257     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1183     Document Type: Article

References (31)

1. Frazer R, Irvine AE and McMullin MF: Chronic myeloid leukaemia in the 21st century. Ulster Med J 76: 8-17, 2007.
2. Faderl S, Talpaz M, Estrov Z and Kantarjian HM: Chronic myelogenous leukemia: biology and therapy. Ann Intern Med 131: 207-219, 1999.
3. Nowefl PC and Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 142: 1497, 1960.
4. Rowley JD: Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290-293, 1973.
5. Tefferi A, Bren GD, Wagner KV, Schaid DJ, Ash RC and Thibodeau SN: The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia 4: 839-842, 1990.
6. Lugo TG, Pendergast AM, Muller AJ and Witte ON: Tyrosine kinase activity and transformation potency of BCR-ABL oncogene products. Science 247: 1079-1082, 1990.
7. Shtivelman E, Lifshitz B, Gale RP and Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315: 550-554, 1985.
8. Mitelman F, Johansson B and Mertens F: The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245, 2007.
9. Ha KC, Lalonde E, Li L, et al: Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines. BMC Med Genomics 4: 75, 2011.
10. Maher CA, Kumar-Sinha C, Cao X, et al: Transcriptome sequencing to detect gene fusions in cancer. Nature 458: 97-101, 2009.
11. Tang F, Barbacioru C, Wang Y, et al: mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods 6: 377-382, 2009.
12. Mortazavi A, Williams BA, McCue K, Schaeffer L and Wold B: Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628, 2008.
13. Wang Z, Gerstein M and Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63, 2009.
14. Trapnell C, Pachter L and Salzberg SL: Top Hat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111, 2009.
15. Roberts A, Trapnell C, Donaghey J, Rinn JL and Pachter L: Improving RNA-Seq expression estimates by correcting for fragment bias. Genome Biol 12: R22, 2011.
16. Jiang H and Wong WH: Statistical inferences for isoform expression in RNA-Seq. Bioinformatics 25: 1026-1032, 2009.
17. Hubbard TJ, Aken BL, Ayling S, et al: Ensembl 2009. Nucleic Acids Res 37: D690-D697, 2009.
18. McPherson A, Hormozdiari F, Zayed A, et al: deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 7: e1001138, 2011.
19. Kim D and Salzberg SL: Top Hat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 12: R72, 2011.
20. Steidl C, Shah SP, Woolcock BW, et al: MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471: 377-381, 2011.
21. Nacu S, Yuan W, Kan Z, et al: Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples. BMC Med Genomics 4: 11, 2011.
22. Melo JV, Gordon DE, Cross NC and Goldman JM: The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 81: 158-165, 1993.
23. Quintas-Cardama A and Cortes J: Molecular biology of BCR-ABL1-positive chronic myeloid leukemia. Blood 113: 1619-1630, 2009.
24. Deininger MW, Goldman JM and Melo JV: The molecular biology of chronic myeloid leukemia. Blood 96: 3343-3356, 2000.
25. Verma D, Kantarjian HM, Jones D, et al: Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes and prognostic significance. Blood 114: 2232-2235, 2009.
26. Skotheim RI, Thomassen GO, Eken M, et al: A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis. Mol Cancer 8: 5, 2009.
27. Chen W, Kalscheuer V, Tzschach A, et al: Mapping translocation breakpoints by next-generation sequencing. Genome Res 18: 1143-1149, 2008.
28. Campbell PJ, Stephens PJ, Pleasance ED, et al: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40: 722-729, 2008.
29. Hermans A, Selleri L, Gow J and Grosveld GC: Absence of alternative splicing in BCR-ABL mRNA in chronic myeloid leukemia cell lines. Blood 72: 2066-2069, 1988.
30. Vincourt JB, Jullien D, Amalric F and Girard JP: Molecular and functional characterization of SLC26A11, a sodium-independent sulfate transporter from high endothelial venules. FASEB J 17: 890-892, 2003.
31. Pruitt KD, Tatusova T and Maglott DR: NCBI Reference Sequence (Ref Seq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 33: D501-504, 2005.